Home  >  Products  >  HARS (histidyl-tRNA synthetase ) Blocking Peptide (the N terminal of HARS)(100ug)
HARS (histidyl-tRNA synthetase ) Blocking Peptide (the N terminal of HARS)(100ug)

HARS (histidyl-tRNA synthetase ) Blocking Peptide (the N terminal of HARS)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-HARS Antibody (ARP61337_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61337
Size: 100ug
Weight: 56kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. The protein encoded by this gene is a cytoplasmic enzyme which belongs to the class II family of aminoacyl-tRNA synthetases. The enzyme is responsible for the synthesis of histidyl-transfer RNA, which is essential for the incorporation of histidine into proteins. The gene is located in a head-to-head orientation with HARSL on chromosome five, where the homologous genes share a bidirectional promoter. The gene product is a frequent target of autoantibodies in the human autoimmune disease polymyositis/dermatomyositis.
Alternative names: FLJ20491; HRS
See Full Product Listings >